Schroder Investment Management Group Alnylam Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 47,342 shares of ALNY stock, worth $11.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,342

Previous 56,724 16.54%

Holding current value

$11.5 Million

Previous $13.8 Million 5.52%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $2.19 Million - $2.69 Million	-9,382 Reduced 16.54%	47,342 $13 Million
Q2 2024 Aug 12, 2024	SELL	$143.31 - $247.0 $4.61 Million - $7.95 Million	-32,178 Reduced 36.19%	56,724 $13.8 Million
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $6.51 Million - $8.81 Million	44,427 Added 99.89%	88,902 $13.3 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $5.57 Million - $7.24 Million	36,820 Added 480.99%	44,475 $8.51 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $93,581 - $115,984	-548 Reduced 6.68%	7,655 $1.36 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $122,291 - $140,165	-661 Reduced 7.46%	8,203 $1.56 Million
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $70,141 - $90,443	384 Added 4.53%	8,864 $1.78 Million
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $110,946 - $144,303	-598 Reduced 6.59%	8,480 $2.02 Million
Q3 2022 Nov 10, 2022	SELL	$138.54 - $232.0 $241,752 - $404,840	-1,745 Reduced 16.12%	9,078 $1.82 Million
Q2 2022 Aug 11, 2022	BUY	$120.42 - $169.29 $107,294 - $150,837	891 Added 8.97%	10,823 $1.58 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $536,826 - $734,074	4,221 Added 73.91%	9,932 $1.64 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $120,946 - $158,641	758 Added 15.3%	5,711 $968,000
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $50,415 - $61,695	297 Added 6.38%	4,953 $935,000
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $117,181 - $161,146	911 Added 24.33%	4,656 $789,000
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $24,965 - $34,090	206 Added 5.82%	3,745 $508,000
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $159,858 - $239,978	1,534 Added 76.51%	3,539 $524,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $112,768 - $162,261	-1,211 Reduced 37.66%	2,005 $225,000
Q4 2017 Feb 09, 2018	BUY	$114.49 - $139.98 $368,199 - $450,175	3,216	3,216 $409,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Alnylam Pharmaceuticals, Inc. Transaction History